Citius Pharmaceuticals, Inc. — Investor Relations & Filings
Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company that develops and commercializes critical care products. The company's diversified pipeline focuses on anti-infectives in adjunct cancer care, stem cell therapies, and prescription products. Its portfolio includes LYMPHIR™, an FDA-approved therapy for adult patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL). Key product candidates in development include Mino-Lok®, an antibiotic lock solution intended to treat patients with catheter-related bloodstream infections, and Halo-Lido, a topical formulation for the treatment of hemorrhoids. Additionally, the company is advancing a stem cell therapy platform for conditions such as acute respiratory distress syndrome (ARDS).
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| CURRENT REPORT | 2026-06-01 | English | |
| REGISTRATION STATEMENT | 2026-05-22 | English | |
| CURRENT REPORT | 2026-05-15 | English | |
| QUARTERLY REPORT | 2026-05-15 | English | |
| 8-K - Citius Pharmaceuticals, Inc. (0001506251) (Filer) | 2026-04-24 | English | |
| 424B5 - Citius Pharmaceuticals, Inc. (0001506251) (Filer) | 2026-04-24 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47923554 | CURRENT REPORT | 2026-06-01 | English | ||
| 46860857 | REGISTRATION STATEMENT | 2026-05-22 | English | ||
| 46362590 | CURRENT REPORT | 2026-05-15 | English | ||
| 46363360 | QUARTERLY REPORT | 2026-05-15 | English | ||
| 36278647 | 8-K - Citius Pharmaceuticals, Inc. (0001506251) (Filer) | 2026-04-24 | English | ||
| 36137720 | 424B5 - Citius Pharmaceuticals, Inc. (0001506251) (Filer) | 2026-04-24 | English | ||
| 33641001 | 8-K - Citius Pharmaceuticals, Inc. (0001506251) (Filer) | 2026-04-06 | English | ||
| 33122239 | 8-K - Citius Pharmaceuticals, Inc. (0001506251) (Filer) | 2026-03-31 | English | ||
| 32892870 | 8-K - CITIUS PHARMACEUTICALS, INC. (0001506251) (Filer) | 2026-03-04 | English | ||
| 32892869 | ARS - CITIUS PHARMACEUTICALS, INC. (0001506251) (Filer) | 2026-02-24 | English | ||
| 32892871 | DEF 14A - CITIUS PHARMACEUTICALS, INC. (0001506251) (Filer) | 2026-02-24 | English | ||
| 30211696 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 30211698 | 10-Q Filing | 2026-02-13 | English | ||
| 30211695 | 8-K Filing | 2026-02-13 | English | ||
| 30211697 | 10-K/A Filing | 2026-01-28 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Biocon Ltd.
Develops biosimilars and novel biologics for diabetes, onco…
|
BIOCON | IN | Manufacturing |
|
BIOCRYST PHARMACEUTICALS INC
Develops novel medicines for patients with rare and serious…
|
BCRX | US | Manufacturing |
|
Biocure Technology Inc.
Develops and commercializes advanced biological medicines, …
|
CURE.X | CA | Manufacturing |
|
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Develops novel antibody-based drugs and provides integrated…
|
2315 | HK | Manufacturing |
|
Biodexa Pharmaceuticals Plc
Clinical-stage biopharma developing treatments for rare dis…
|
BDRX | GB | Manufacturing |
|
BioDlink International Company Limited
Integrated biopharmaceutical CDMO specializing in ADC platf…
|
1875 | HK | Manufacturing |
|
BioEnvelop Technologies Corporation
Developed rapidly dissolving edible film strips for nutrace…
|
BIE | CA | Manufacturing |
|
Biofarm S.A.
A pharmaceutical company that manufactures and markets medi…
|
BIO | RO | Manufacturing |
|
BIO-FD&C CO.,LTD.
Develops active ingredients for cosmetics and pharma using …
|
251120 | KR | Manufacturing |
|
Biofil Chemicals & Pharmaceuticals
Produces pharmaceutical formulations, bulk drugs, and plast…
|
BIOFILCHEM | IN | Manufacturing |
Citius Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34965/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34965 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34965 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34965 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34965}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Citius Pharmaceuticals, Inc. (id: 34965)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.